Posts Tagged ‘ urology ’

Carpenter v. American Medical Systems Trial Delayed

May 8th, 2013 | By
Carpenter v. American Medical Systems Trial Delayed

May 8, 2013 ~ The trial of Marion Carpenter v. American Medical Systems which was scheduled to begin in San Bernardino California, May 13th, has been delayed until January or February of 2014. Attorney Stewart Albertson tells MDND that decision was made by both sides appearing before Judge Bryan F. Foster, in the San Bernardino
[continue reading...]



Teapapers: Back from Surgery at UCLA

Apr 25th, 2013 | By
Teapapers: Back from Surgery at UCLA

April 25, 2013~ Once again our prolific patient advocate enlightens and educates women considering traveling across the country to go to University of California Los Angeles (UCLA) to have surgery. This time Linda had reconstruction and the anchoring of her bladder after mesh removal last October. This followup visit is part of the reconstruction that
[continue reading...]



Suffering in Silence: Diane Maassen Tells FDA Panel About Her Nightmare with Pelvic Mesh Sling

Sep 16th, 2011 | By
Suffering in Silence: Diane Maassen Tells FDA Panel About Her Nightmare with Pelvic Mesh Sling

SEPTEMBER 16, 2011 – Editors Note: I attended the Food and Drug Administration expert panel convened on September 8 & 9, 2011 to listen to patients and industry as well as surgeons who use pelvic mesh to treat incontinence and pelvic floor weakness in women and hernias in men. All of the injured patients were
[continue reading...]



We hope you find this a helpful resource. National News Editor, Jane Akre, began MDND with the hope of providing the latest news, information and perspective from the regulatory, industry and patient point of view, something that goes under-reported in much of the coverage of medical devices. The public is just now becoming aware that many devices do not undergo the same scrutiny as prescription drugs and are instead grandfathered in under an FDA loophole that has gone largely unchanged since the 1970s. As a result, patients become the post-market clinical trial subjects, and many suffer devastating and permanent injuries.